期刊文献+

双氯芬酸钠联合盐酸乙哌立松应用于腰腿痛治疗的临床价值探析 被引量:2

The Clinical Value Study on Diclofenac Sodium Combined with Eperisone Hydrochloride in the Treatment of Lumbocrural Pain
下载PDF
导出
摘要 目的探讨分析双氯芬酸钠联合盐酸乙哌立松应用于腰腿痛治疗的临床价值。方法随机选取2014年1月—2015年1月该院收治的100例腰腿痛患者为研究对象,随机分成对照组与实验组,对照组患者50例,采用双氯芬酸钠进行治疗;实验组患者50例,采用双氯芬酸钠联合盐酸乙哌立松进行治疗,察观两组患者的总不良反应情况、临床疗效以及疼痛评分。结果对照组患者的总有效率为80.00%,总不良反应率为28.00%;实验组患者的总有效率为96.00%,总不良反应率为4.00%,且实验组患者疼痛改善情况明显优于对照组,实验组与对照组比较P<0.05,差异有统计学意义。结论双氯芬酸钠联合盐酸乙哌立松治疗腰腿痛有显著临床效果,值得临床应用并推广。 Objective To study and analyze the clinical value of diclofenac sodium combined with eperisone hydrochloride in the treatment of lumbocrural pain. Methods 100 cases of patients with lumbocrural pain treated in our hospital from Jan-uary 2014 to January 2015 were selected as the research object and randomly divided into the control group and the experi-mental group with 50 cases in each, the control group were given diclofenac sodium treatment and the experimental group were given diclofenac sodium combined with eperisone hydrochloride treatment, and total adverse effects, clinical efficacy, and pain scores of the two groups were observed. Results The total effective rate and the total adverse reaction rate of the control group was respectively 80.00% and 28.00%, 96.00% and 4.00% of the experimental group, and the improvement of pain in the experimental group was significantly better than that in the control group, the difference between the experimen-tal group and the control group by comparison was statistically significant (P〈0.05). Conclusion The clinical effect of di-clofenac sodium combined with eperisone hydrochloride in the treatment of lumbocrural pain is significant, which is worthy of clinical application and promotion.
出处 《中外医疗》 2015年第34期142-143,167,共3页 China & Foreign Medical Treatment
关键词 双氯芬酸钠 盐酸乙哌立松 腰腿痛 Diclofenac sodium Eperisone hydrochloride Lumbocrural pain
  • 相关文献

参考文献7

二级参考文献27

  • 1刘钵城,韦玉.骶管注药治疗腰椎间盘突出症47例报告[J].颈腰痛杂志,1996,17(1):43-44. 被引量:17
  • 2曹高忠,滕红林,吴春雷,刘爱月,吴云刚,吴剑静.盐酸乙哌立松联合塞来昔布治疗颈肩腰背痛75例疗效分析[J].中国临床药学杂志,2007,16(5):309-311. 被引量:1
  • 3Hoshino AC, Ferreira HP, Maim O, et ai. A systematic review of mercury ototoxicity [J]. Cad Saude Publica, 2012, 28 (7) : 1239 - 1248.
  • 4Chan TY. Inorganic mercury poisoning associated with skin - lightening cosmetic products [J]. Clin Toxicol (Phila), 2011, 49 (10): 886 - 891.
  • 5Peregrino CP, Moreno MV, Miranda SV, et al. Mercury levels in lo- cally manufactured Mexican skin - lightening creams [ J ]. Int J Environ Res public Health, 2011, 8 (6) : 2516 -2523.
  • 6Wu ML, Deng JF, Lin KP, et al. Lead, mercury, and arsenic poi- soning due to topical use of traditional chinese medicines [ J ]. Am J Med, 2013, 126 (5): 451-454.
  • 7Su sY,Cheng CY, Tsai TH. Paeonol attenuates H202-induced NF-KB-associated arnyloid precursor protein expression[J]. Am J Chin Meal,2010,38(6) : 1171-1192.
  • 8Han S, Park HS, Pee YH, et al. The clinical characteristics of lower lumbar osteoporotic compression fractures treated by percutaneous vertebroplasty : a comparative analysis of 120 cases [J]. Korean J Spine, 2013, 10: 221-226.
  • 9Limke JC, Rainville J, Pena E, et al. Randomized trial comparing the effects of one set vs two sets of resistance exercises for outpatients with chronic low back pain and leg pain[J-1. Eur J Phys Rehabil Med, 2008, 44: 399-405.
  • 10Ghia JN, Duncan G, pharmacologic approach chronic pain[J]. Spine 447-451.

共引文献27

同被引文献23

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部